1. Zhao J, Gonzalez F, Mu D. Apnea of prematurity: from cause to treatment. Eur J Pediatr. 2011;170(9):1097-105. 
2. Eichenwald EC; Committee on Fetus and Newborn, American Academy of Pediatrics. Apnea of Prematurity. Pediatrics. 2016;137(1):e20153757. 
3. Picone F, Aufieri R, Paolillo P. Apnea of prematurity: challenges and solutions. Res Rep Neonatol. 2014;4:101-9. 
4. Mathew OP. Apnea of prematurity: pathogenesis and management strategies. J Perinatol. 2011;31(5):302-10. 
5. Mishra S, Agarwal R, Jeevasankar M, Aggarwal R, Deorari AK, Vinod KP. Apnea in the Newborn. 2007. [cited 2018 May 25]. Available from: http://www.newbornwhocc.org/>http://www.newbornwhocc.org/ 
6. Martin RJ, Wilson CG. Apnea of prematurity. Compr Physiol. 2012;2(4):2923-31. 
7. Peček J, Fister P. Srčno-dihalni vzorci novorojenčkov. Med Razgl. 2018;57(3):325-43. 
8. Sarnat HB, Flores-Sarnat L. Synaptogenesis and myelination in the nucleus/tractus solitarius: potential role in apnea of prematurity, congenital central hypoventilation, and sudden infant death syndrome. J Child Neurol. 2016;31(6):722-32. 
9. Martin RJ, Di Fiore JM, Walsh MC. Hypoxic episodes in bronchopulmonary dysplasia. Clin Perinatol. 2015;42(4):825-38. 
10. Martin RJ, Di Fiore JM, Macfarlane PM, Wilson CG. Physiologic basis for intermittent hypoxic episodes in preterm infants. Adv Exp Med Biol. 2012;758:351-8. 
11. Heman-Ackah YD, Pernell KJ, Goding GS. The laryngeal chemoreflex: an evaluation of the normoxic response. Laryngoscope. 2009;119(2):370-9. 
12. Thach BT. Reflux associated apnea in infants: evidence for a laryngeal chemoreflex. Am J Med. 1997;103(5):120S-4S. 
13. Xia L, Leiter JC, Bartlett D. Laryngeal reflex apnea in neonates: effects of CO2 and the complex influence of hypoxia. Respir Physiol Neurobiol. 2013;186(1):109-13. 
14. Schelegle ES. Functional morphology and physiology of slowly adapting pulmonary stretch receptors. Anat Rec A Discov Mol Cell Evol Biol. 2003;270(1):11-6. 
15. Alvarado RE. Control of breathing and apnea of prematurity. Neoreviews. 2018;19(4):e224-34. 
16. Bratanič B, Paro Panjan D. Apnoične atake. In: Kržišnik C, Anderluh M, Arnež M, ur. Pediatrija. Ljubljana: DZS; 2014. pp. 223-4. 
17. Martin RJ, Wilson CG. What to do about apnea of prematurity? J Appl Physiol (1985). 2009;107(4):1015-6. 
18. Robek D, Soltirovska Šalamon A. Neonatalne konvulzije. Slov Pediatr. 2018;25:148-56. 
19. Westkamp E, Soditt V, Adrian S, Bohnhorst B, Groneck P, Poets CF. Blood transfusion in anemic infants with apnea of prematurity. Biol Neonate. 2002;82(4):228-32. 
20. Slocum C, Hibbs AM, Martin RJ, Orenstein SR. Infant apnea and gastroesophageal reflux: a critical review and framework for further investigation. Curr Gastroenterol Rep. 2007;9(3):219-24. 
21. Arad-Cohen N, Cohen A, Tirosh E. The relationship between gastroesophageal reflux and apnea in infants. J Pediatr. 2000;137(3):321-6. 
22. Amin RS. Gastroesophageal reflux and infant apnea. J Pediatr. 2000;137(3):298-300. 
23. Rambaud C, Guilleminault C. “Back to sleep” and unexplained death in infants. Sleep. 2004;27(7):1359-66. 
24. Lemyre B, Davis PG, De Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity. Cochrane Database Syst Rev. 2000(3):CD002272. 
25. Kubicka ZJ, Limauro J, Darnall RA. Heated, humidified high-flow nasal cannula therapy: yet another way to deliver continuous positive airway pressure? Pediatrics. 2008;121(1):82-8. 
26. Henderson-Smart DJ, De Paoli AG. Prophylactic methylxanthine for prevention of apnoea in preterm infants. Cochrane Database Syst Rev. 2010;12(12):CD000432. 
27. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al.; Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112-21. 
28. Shrestha B, Jawa G. Caffeine citrate - Is it a silver bullet in neonatology? Pediatr Neonatol. 2017;58(5):391-7. 
29. Neubauer D, Erjavec M. Uporaba kardiorespirografije v neonatologiji. Zdravstveno varstvo v perinatalni dobi. 1983;1983:65-7. 
30. Doyle J, Davidson D, Katz S, Varela M, Demeglio D, DeCristofaro J. Apnea of prematurity and caffeine pharmacokinetics: potential impact on hospital discharge. J Perinatol. 2016;36(2):141-4. 
31. Aranda JV, Collinge JM, Zinman R, Watters G. Maturation of caffeine elimination in infancy. Arch Dis Child. 1979;54(12):946-9. 
32. Aranda JV, Turmen T, Davis J, Trippenbach T, Grondin D, Zinman R, et al. Effect of caffeine on control of breathing in infantile apnea. J Pediatr. 1983;103(6):975-8. 
33. Henderson-Smart D, Steer P. Doxapram treatment for apnea in preterm infants. Cochrane Database Syst Rev. 2004(4):CD000074. 
34. Al-Saif S, Alvaro R, Manfreda J, Kwiatkowski K, Cates D, Qurashi M, et al. A randomized controlled trial of theophylline versus CO2 inhalation for treating apnea of prematurity. J Pediatr. 2008;153(4):513-8. 
35. Edraki M, Pourpulad H, Kargar M, Pishva N, Zare N, Montaseri H. Olfactory stimulation by vanillin prevents apnea in premature newborn infants. Iran J Pediatr. 2013;23(3):261-8. 
36. Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics. 1997;100(3 Pt 1):354-9. 
37. Tamim H, Khogali M, Beydoun H, Melki I, Yunis K; National Collaborative Perinatal Neonatal Network. Consanguinity and apnea of prematurity. Am J Epidemiol. 2003;158(10):942-6. 
38. Bloch-Salisbury E, Hall MH, Sharma P, Boyd T, Bednarek F, Paydarfar D. Heritability of apnea of prematurity: a retrospective twin study. Pediatrics. 2010;126(4):e779-87. 
39. Kumral A, Tuzun F, Yesilirmak DC, Duman N, Ozkan H. Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity. Acta Paediatr. 2012;101(7):e299-303. 
